{"success":true,"data":{"pressRelease":{"id":"5655","rtpr_id":"nNFCqPK85","ticker":"DHB","exchange":"","all_tickers":["DHB"],"title":"Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)","author":"Newsfile Corp","published_at":"2026-04-22T21:45:15.094Z","article_body":"Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Delivra\nHealth Brands Inc. (TSXV: DHB) OTCQB: DHBUF) (\"Delivra Health\" or the\n\"Company\"), a consumer packaged goods company uniquely positioned in the\nhealth and wellness sector, announced today that its wholly-owned subsidiary,\nLivCorp Inc., has entered into a licence agreement (\"Licence Agreement\") with\nPeak Processing Solutions (\"Peak\") (ASX: PKP), to manufacture, distribute and\nsell infused LivRelief(™) branded topicals in Canada.\n\nThe Licence Agreement with Peak was signed on April 22, 2026. The term of the\nLicence Agreement with Peak is five (5) years, renewing automatically\nthereafter for three (3) further terms of three (3) years each.\n\n\"We are very pleased to announce our Licence Agreement with Peak, as a\nstrategic and long term partner, to strengthen the market position for our\nLivRelief (https://api.newsfilecorp.com/redirect/Mq5xZhq5mJ) Infused(™)\ntopicals,\" said Gord Davey, President and Chief Executive Officer of Delivra\nHealth. \"We expect our partnership with Peak to realize benefits well beyond\nDelivra's existing processing and distribution channels. Peak's deep expertise\nin consumer-packaged goods makes them a natural fit to accelerate the growth\nand reach of the LivRelief Infused(™) brand.\"\n\n\"We are excited to partner with Delivra Health and bring the LivRelief\nInfused™ brand under Peak's manufacturing platform,\" said Barry Katzman,\nChief Executive Officer of Peak \"Delivra Health's commitment to innovation and\nproduct quality aligns perfectly with our focus on operational excellence and\nconsumer trust. Together, we look forward to driving growth in the infused\ntopicals category and expanding access to this well-recognized Canadian\nwellness brand.\"\n\nLivRelief Infused™ topicals will be available in three unique SKUs: (i) a\nCBD-only formulation containing 500mgs of CBD with cooling effects; (ii) a 1:1\nformat formulation containing 250mgs of THC and 250mgs of CBD; and (iii) an\nextra strength CBD topical cream containing 1,200mgs of CBD.\n\n(https://images.newsfilecorp.com/files/2413/293877_delivra.jpg)\n\nTo view an enhanced version of this graphic, please visit:\nhttps://images.newsfilecorp.com/files/2413/293877_delivra.jpg\n\nIn addition to the above, the Company announced that, pursuant to a resolution\npassed by the Company's Board of Directors on April 22, 2026, it has granted\nan aggregate of 440,000 incentive stock options (the \"Options\") under the\nCompany's 10% fixed stock option plan, to certain directors, officers,\nemployees, and consultants of the Company. The Options are exercisable at a\nprice of $0.14 per common share, will have a term of five years from the date\nof grant, and will vest 1/3 annually from the date of grant. The Options are\nsubject to the terms and conditions prescribed by the TSX Venture Exchange,\nand applicable securities laws.\n\nAbout Delivra Health Brands Inc.\n\nHelping people take control of their health with alternative wellness\nsolutions is what energizes the Delivra Health team! The Delivra Health\nportfolio features innovative brands like Dream Water™ and LivRelief™,\nwhich deliver relief from common everyday issues like chronic pain, anxiety,\nand sleeplessness. Delivra Health products have allowed millions of customers\nto reclaim their mobility, energy, and in turn, quality of life. The websites\nof the Company's two subsidiaries are  Dream Water™\n(https://api.newsfilecorp.com/redirect/bgKZAf17AN) and  LivRelief\n(https://api.newsfilecorp.com/redirect/3KZzeCepWK)(™). For more information,\nplease visit  www.delivrahealthbrands.com.\n\nAbout Peak Processing\n\nPeak Processing Limited (ASX: PKP) is a leading FMCG organisation providing\nthe best in class manufacturing, sales, and distribution solutions for THC and\nCBD products specializing in beverages. Peak Processing develops premium,\ncompliant products that resonate with adult consumers in regulated global\nmarkets, including USA and Canada.\n\nVisit www.peakprocessing.com\n\nCautionary Note Regarding Forward-Looking Statements\n\nThis news release contains \"forward-looking information\" and \"forward-looking\nstatements\" (collectively, \"forward-looking statements\") within the meaning of\nthe applicable Canadian securities legislation. All statements, other than\nstatements of historical fact, are forward-looking statements and are based on\nexpectations, estimates, and projections as at the date of this news release.\nAny statement that involves discussions with respect to predictions,\nexpectations, beliefs, plans, projections, objectives, assumptions, future\nevents or performance (often but not always using phrases such as \"expects\",\nor \"does not expect\", \"is expected\", \"anticipates\" or \"does not anticipate\",\n\"plans\", \"budget\", \"scheduled\", \"forecasts\", \"estimates\", \"believes\" or\n\"intends\" or variations of such words and phrases or stating that certain\nactions, events or results \"may\" or \"could\", \"would\", \"might\" or \"will\" be\ntaken to occur or be achieved) are not statements of historical fact and may\nbe forward-looking statements. In this news release, forward-looking\nstatements include, among other things, statements with respect to the\nCompany's products offering relief from chronic pain, anxiety, and\nsleeplessness, expectations regarding the market position of the Company's\nLivRelief Infused(™) topicals, the growth and reach of the LivRelief\nInfused(™) brand, and impacts of the Company's partnership with Peak,\nincluding expectations of benefits to Delivra's existing product line and\nbeyond.\n\nThese forward-looking statements are based on reasonable assumptions and\nestimates of management of the Company at the time such statements were made.\nActual future results may differ materially as forward-looking statements\ninvolve known and unknown risks, uncertainties, and other factors which may\ncause the actual results, performance, or achievements of the Company to\nmaterially differ from any future results, performance, or achievements\nexpressed or implied by such forward-looking statements. Such factors, among\nother things, include: fluctuations in general macroeconomic conditions;\nfluctuations in securities markets; expectations regarding the size of the\ncannabis markets where the Company operates; changing consumer habits; the\nability of the Company to successfully achieve its business objectives; plans\nfor expansion; political and social uncertainties; inability to obtain\nadequate insurance to cover risks and hazards; employee relations and the\npresence of laws and regulations that may impose restrictions on cultivation,\nproduction, distribution, and sale of cannabis and cannabis-related products\nin the markets where the Company operates. Although the forward-looking\nstatements contained in this news release are based upon what management of\nthe Company believes, or believed at the time, to be reasonable assumptions,\nthe Company cannot assure shareholders that actual results will be consistent\nwith such forward-looking statements, as there may be other factors that cause\nresults not to be as anticipated, estimated or intended. Readers should not\nplace undue reliance on the forward-looking statements and information\ncontained in this news release. The Company assumes no obligation to update\nthe forward-looking statements of beliefs, opinions, projections, or other\nfactors, should they change, except as required by law.\n\nAdditional information regarding this and other risks and uncertainties\nrelating to the Company's business are contained under the heading \"Risk\nFactors\" in the Company's latest annual information form, and under the\nheading \"Risks and Uncertainties\" in the Company's latest management\ndiscussion and analysis under the Company's profile on SEDAR+ at\nwww.sedarplus.ca.\n\nNeither TSX-V nor its Regulation Services Provider (as that term is defined in\nthe policies of the TSX-V) accept responsibility for the adequacy or accuracy\nof this release.\n\nInvestor Relations:\nJack Tasse\nChief Financial Officer\nIR@delivrahealth.com\n1-877-915-7934\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/293877","article_body_html":"","raw_payload":{"data":{"id":"nNFCqPK85","title":"Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)","author":"Newsfile Corp","ticker":"DHB","created":"2026-04-22T21:45:15.094Z","tickers":["DHB"],"exchange":"","article_body":"Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Delivra\nHealth Brands Inc. (TSXV: DHB) OTCQB: DHBUF) (\"Delivra Health\" or the\n\"Company\"), a consumer packaged goods company uniquely positioned in the\nhealth and wellness sector, announced today that its wholly-owned subsidiary,\nLivCorp Inc., has entered into a licence agreement (\"Licence Agreement\") with\nPeak Processing Solutions (\"Peak\") (ASX: PKP), to manufacture, distribute and\nsell infused LivRelief(™) branded topicals in Canada.\n\nThe Licence Agreement with Peak was signed on April 22, 2026. The term of the\nLicence Agreement with Peak is five (5) years, renewing automatically\nthereafter for three (3) further terms of three (3) years each.\n\n\"We are very pleased to announce our Licence Agreement with Peak, as a\nstrategic and long term partner, to strengthen the market position for our\nLivRelief (https://api.newsfilecorp.com/redirect/Mq5xZhq5mJ) Infused(™)\ntopicals,\" said Gord Davey, President and Chief Executive Officer of Delivra\nHealth. \"We expect our partnership with Peak to realize benefits well beyond\nDelivra's existing processing and distribution channels. Peak's deep expertise\nin consumer-packaged goods makes them a natural fit to accelerate the growth\nand reach of the LivRelief Infused(™) brand.\"\n\n\"We are excited to partner with Delivra Health and bring the LivRelief\nInfused™ brand under Peak's manufacturing platform,\" said Barry Katzman,\nChief Executive Officer of Peak \"Delivra Health's commitment to innovation and\nproduct quality aligns perfectly with our focus on operational excellence and\nconsumer trust. Together, we look forward to driving growth in the infused\ntopicals category and expanding access to this well-recognized Canadian\nwellness brand.\"\n\nLivRelief Infused™ topicals will be available in three unique SKUs: (i) a\nCBD-only formulation containing 500mgs of CBD with cooling effects; (ii) a 1:1\nformat formulation containing 250mgs of THC and 250mgs of CBD; and (iii) an\nextra strength CBD topical cream containing 1,200mgs of CBD.\n\n(https://images.newsfilecorp.com/files/2413/293877_delivra.jpg)\n\nTo view an enhanced version of this graphic, please visit:\nhttps://images.newsfilecorp.com/files/2413/293877_delivra.jpg\n\nIn addition to the above, the Company announced that, pursuant to a resolution\npassed by the Company's Board of Directors on April 22, 2026, it has granted\nan aggregate of 440,000 incentive stock options (the \"Options\") under the\nCompany's 10% fixed stock option plan, to certain directors, officers,\nemployees, and consultants of the Company. The Options are exercisable at a\nprice of $0.14 per common share, will have a term of five years from the date\nof grant, and will vest 1/3 annually from the date of grant. The Options are\nsubject to the terms and conditions prescribed by the TSX Venture Exchange,\nand applicable securities laws.\n\nAbout Delivra Health Brands Inc.\n\nHelping people take control of their health with alternative wellness\nsolutions is what energizes the Delivra Health team! The Delivra Health\nportfolio features innovative brands like Dream Water™ and LivRelief™,\nwhich deliver relief from common everyday issues like chronic pain, anxiety,\nand sleeplessness. Delivra Health products have allowed millions of customers\nto reclaim their mobility, energy, and in turn, quality of life. The websites\nof the Company's two subsidiaries are  Dream Water™\n(https://api.newsfilecorp.com/redirect/bgKZAf17AN) and  LivRelief\n(https://api.newsfilecorp.com/redirect/3KZzeCepWK)(™). For more information,\nplease visit  www.delivrahealthbrands.com.\n\nAbout Peak Processing\n\nPeak Processing Limited (ASX: PKP) is a leading FMCG organisation providing\nthe best in class manufacturing, sales, and distribution solutions for THC and\nCBD products specializing in beverages. Peak Processing develops premium,\ncompliant products that resonate with adult consumers in regulated global\nmarkets, including USA and Canada.\n\nVisit www.peakprocessing.com\n\nCautionary Note Regarding Forward-Looking Statements\n\nThis news release contains \"forward-looking information\" and \"forward-looking\nstatements\" (collectively, \"forward-looking statements\") within the meaning of\nthe applicable Canadian securities legislation. All statements, other than\nstatements of historical fact, are forward-looking statements and are based on\nexpectations, estimates, and projections as at the date of this news release.\nAny statement that involves discussions with respect to predictions,\nexpectations, beliefs, plans, projections, objectives, assumptions, future\nevents or performance (often but not always using phrases such as \"expects\",\nor \"does not expect\", \"is expected\", \"anticipates\" or \"does not anticipate\",\n\"plans\", \"budget\", \"scheduled\", \"forecasts\", \"estimates\", \"believes\" or\n\"intends\" or variations of such words and phrases or stating that certain\nactions, events or results \"may\" or \"could\", \"would\", \"might\" or \"will\" be\ntaken to occur or be achieved) are not statements of historical fact and may\nbe forward-looking statements. In this news release, forward-looking\nstatements include, among other things, statements with respect to the\nCompany's products offering relief from chronic pain, anxiety, and\nsleeplessness, expectations regarding the market position of the Company's\nLivRelief Infused(™) topicals, the growth and reach of the LivRelief\nInfused(™) brand, and impacts of the Company's partnership with Peak,\nincluding expectations of benefits to Delivra's existing product line and\nbeyond.\n\nThese forward-looking statements are based on reasonable assumptions and\nestimates of management of the Company at the time such statements were made.\nActual future results may differ materially as forward-looking statements\ninvolve known and unknown risks, uncertainties, and other factors which may\ncause the actual results, performance, or achievements of the Company to\nmaterially differ from any future results, performance, or achievements\nexpressed or implied by such forward-looking statements. Such factors, among\nother things, include: fluctuations in general macroeconomic conditions;\nfluctuations in securities markets; expectations regarding the size of the\ncannabis markets where the Company operates; changing consumer habits; the\nability of the Company to successfully achieve its business objectives; plans\nfor expansion; political and social uncertainties; inability to obtain\nadequate insurance to cover risks and hazards; employee relations and the\npresence of laws and regulations that may impose restrictions on cultivation,\nproduction, distribution, and sale of cannabis and cannabis-related products\nin the markets where the Company operates. Although the forward-looking\nstatements contained in this news release are based upon what management of\nthe Company believes, or believed at the time, to be reasonable assumptions,\nthe Company cannot assure shareholders that actual results will be consistent\nwith such forward-looking statements, as there may be other factors that cause\nresults not to be as anticipated, estimated or intended. Readers should not\nplace undue reliance on the forward-looking statements and information\ncontained in this news release. The Company assumes no obligation to update\nthe forward-looking statements of beliefs, opinions, projections, or other\nfactors, should they change, except as required by law.\n\nAdditional information regarding this and other risks and uncertainties\nrelating to the Company's business are contained under the heading \"Risk\nFactors\" in the Company's latest annual information form, and under the\nheading \"Risks and Uncertainties\" in the Company's latest management\ndiscussion and analysis under the Company's profile on SEDAR+ at\nwww.sedarplus.ca.\n\nNeither TSX-V nor its Regulation Services Provider (as that term is defined in\nthe policies of the TSX-V) accept responsibility for the adequacy or accuracy\nof this release.\n\nInvestor Relations:\nJack Tasse\nChief Financial Officer\nIR@delivrahealth.com\n1-877-915-7934\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/293877"},"type":"article","timestamp":"2026-04-22T21:45:15.15729816Z","server_sent_at_ms":1776894315157},"received_at":"2026-04-22T21:45:15.309Z","source_url":"https://www.newsfilecorp.com/release/293877"},"analysis":{"id":"4143","press_release_id":"5655","analysis_json":{"industry":{"label":"Food, Beverage & Tobacco","sector":"Consumer Staples"},"redFlags":[],"eventType":"partnership","narrative":"Delivra Health entered into a five-year licence agreement with Peak Processing Solutions to manufacture and distribute its LivRelief Infused topicals in Canada, leveraging Peak's CPG expertise to accelerate brand growth.\n\nThe product line will consist of three unique SKUs: a 500mg CBD-only formulation, a 250mg THC/250mg CBD 1:1 format, and a 1,200mg extra strength CBD cream.\n\nSeparately, the Board of Directors granted 440,000 incentive stock options to directors, officers, and consultants, exercisable at $0.14 per share over five years.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Strategic manufacturing partnership expands reach for LivRelief Infused brand in Canada."},"keyFigures":{"offeringPrice":0.14,"sharesOffered":440000},"quotedText":"We expect our partnership with Peak to realize benefits well beyond Delivra's existing processing and distribution channels.","namedEntities":{"people":[{"name":"Gord Davey","role":"President and Chief Executive Officer"},{"name":"Barry Katzman","role":"Chief Executive Officer"},{"name":"Jack Tasse","role":"Chief Financial Officer"}],"products":["LivRelief Infused™","Dream Water™","LivRelief™"],"companies":[{"name":"Delivra Health Brands Inc.","ticker":"DHB"},{"name":"LivCorp Inc.","relationship":"wholly-owned subsidiary"},{"name":"Peak Processing Solutions","ticker":"PKP","relationship":"partner"}],"dollarAmounts":[{"amount":"$0.14","context":"incentive stock option exercise price"}]},"materialImpact":{"score":3,"reasoning":"New strategic partnership with Peak Processing expands manufacturing and distribution capabilities for the LivRelief Infused brand in Canada, with a 5-year term indicating long-term commitment. While operationally significant, specific financial terms or revenue projections were not disclosed."},"tickerRelevance":{"others":[{"ticker":"PKP","relevance":"partner"}],"primary":"DHB"},"eventTypeSecondary":["product_launch"]},"event_type":"partnership","event_type_secondary":["product_launch"],"sentiment":"bullish","material_impact_score":3,"narrative":"Delivra Health entered into a five-year licence agreement with Peak Processing Solutions to manufacture and distribute its LivRelief Infused topicals in Canada, leveraging Peak's CPG expertise to accelerate brand growth.\n\nThe product line will consist of three unique SKUs: a 500mg CBD-only formulation, a 250mg THC/250mg CBD 1:1 format, and a 1,200mg extra strength CBD cream.\n\nSeparately, the Board of Directors granted 440,000 incentive stock options to directors, officers, and consultants, exercisable at $0.14 per share over five years.","key_figures":{"offeringPrice":0.14,"sharesOffered":440000},"named_entities":{"people":[{"name":"Gord Davey","role":"President and Chief Executive Officer"},{"name":"Barry Katzman","role":"Chief Executive Officer"},{"name":"Jack Tasse","role":"Chief Financial Officer"}],"products":["LivRelief Infused™","Dream Water™","LivRelief™"],"companies":[{"name":"Delivra Health Brands Inc.","ticker":"DHB"},{"name":"LivCorp Inc.","relationship":"wholly-owned subsidiary"},{"name":"Peak Processing Solutions","ticker":"PKP","relationship":"partner"}],"dollarAmounts":[{"amount":"$0.14","context":"incentive stock option exercise price"}]},"model_name":"glm-4.7","prompt_hash":"sha256:2f2748f0fcc8c4f2","schema_hash":"sha256:ad96b863d7123008","created_at":"2026-04-23T00:41:23.308Z","global_importance":3,"audience_relevance":3,"importance_components":{"method":"backfill-heuristic","signals":{"bodyLong":false,"headlineTier1":false,"tickerCovered":false,"hadSignificance":false},"version":1,"computedAt":"2026-04-27T11:52:54.541Z"}},"durationMs":37124,"modelName":"glm-4.7"}}